Researching the world’s best documented strain.
Our top scientist on researching the LGG® strain.
Since its discovery in 1983 by the two scientists Sherwood Gorbach and Barry Goldin, the LGG® strain has been widely recognized for having unique features required to potentially convey health benefits. Today the LGG® strain is the world’s best-documented probiotic strain, supported by more than 1100 scientific publications and over 300 clinical studies.
But the work is far from over, as our Head of Discovery Adam Baker explains “We are constantly researching to expand our understanding of how each bacterial strain works and what it does to the human body. And this is where the LGG® strain becomes especially interesting, it has so many mechanisms of conferring possible health benefits. And the only way of utilizing these mechanisms is by studying the LGG® strain.”. That is why research and development is top priority at Chr. Hansen, and why the LGG® strain comes with the promise of Scientific Excellence by Chr. Hansen “To us working with the LGG strain, the promise of Scientific Excellence by Chr. Hansen, means dedication and commitment. Working at Chr. Hansen you are carrying forward a 140 years long history of scientific pioneering and probiotic expertize.” says Johan Johan Van Hylckama Vlieg, VP of Microbiome & Human Health Innovation.
State-of-the-art research and the most advanced scientific technologies, allows us to bring forward the understanding of the how the LGG® strain interacts within the human body, and investigate potential health benefits. With the possibility of unknown future benefits, yet to be explored.
“The future of the LGG® strain seems more exciting than ever. I believe that through scientific research we will continue to demonstrate the progress and expand the potential of the LGG® strain.” Anita Wichmann Gustafsson, Senior Research Scientist.